Atezolizumab is a new drug being tested in myeloma. It targets a protein called PDL-1 which is normally involved in dampening the immune response. This increases the activity of the immune system to recognize and destroy myeloma cells.
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with Smoldering Myeloma.
There are no resources, links or videos to display for this treatment.